期刊文献+

肠系膜纤维瘤病一例

原文传递
导出
摘要 患者男,38岁,因“进食后恶心、呕吐40余天”入院。查体:腹部无阳性体征。腹部MRI显示十二指肠空肠交界处异常信号灶呈渐进性不均匀强化。于最后一期强化最明显。考虑十二指肠空肠交界处肿瘤,合并肠腔狭窄、十二指肠梗阻(图1)。
出处 《中华普通外科杂志》 CSCD 北大核心 2016年第6期523-523,共1页 Chinese Journal of General Surgery
  • 相关文献

参考文献4

  • 1Guglielmi G,Cifaratti A, Scalzo G, et al. Imaging of superficial and deep fibromatosis [ J ]. Radiol Med, 2009, 114 ( 8 ) : 1292 - 1307. 被引量:1
  • 2Demetri GD,von Mehren M, Antonescu CR, et al. NCCN task force report: update on the management of patients with gastrointestinal stromal tumors [ J ]. Natl Compr Canc Netw, 2010,8(Suppl 2) : S1-41. 被引量:1
  • 3史恩溢,朱雄增.胃肠道间质瘤的分子分型与靶向治疗[J].中华病理学杂志,2008,37(8):555-558. 被引量:5
  • 4Huss S, Nehles J, Binot E, et al. β-catenin ( CTNNBI ) mutations and clinicopathological features of mesenteric desmoid- type fibromatosis [ J ]. Histopathology, 2013, 62 ( 2 ) :294-304. 被引量:1

二级参考文献35

  • 1贺慧颖,方伟岗,钟镐镐,李燕,郑杰,杜娟,衡万杰,吴秉铨.165例胃肠道间质瘤中c-kit和PDGFRA基因突变的检测和临床诊断意义[J].中华病理学杂志,2006,35(5):262-266. 被引量:73
  • 2詹文华,王鹏志,邵永孚,伍晓汀,顾晋,李荣,万德森,丁克峰,师英强,于吉人,卢辉山,邹小明,毕建威,孙益红,陆云飞,陈道达,张信华.伊马替尼术后辅助治疗胃肠间质瘤的多中心前瞻性临床试验中期报告[J].中华胃肠外科杂志,2006,9(5):383-387. 被引量:85
  • 3Corless CL, Fletcher JA, Heinrich MC. Biology of gastrointestinal stromal tumors. J Clin Oncol, 2004, 22(18) :3813-3825. 被引量:1
  • 4Corless CL, Schroeder A, Griffith D, et al. PDGFRA mutations in gastrointestinal stromal tumors: frequency, spectrum and in vitro sensitivity to imatinib. J Clin Oncol, 2005, 23 (23) :5357-5364. 被引量:1
  • 5Hirota S, Isozaki K, Moriyama Y, et al. Gain-of-function mutations of c-kit in human gastrointestinal stromal tumors. Science, 1998, 279 ( 5350 ) :577-580. 被引量:1
  • 6Kitamura Y, Hirotab S. Kit as a human oncogenic tyrosine kinase. Cell Mol Life Sci, 2004, 61(23) :2924-2931. 被引量:1
  • 7van Oosterom AT, Judson I, Verweij J, et al. Safety and efficacy of imatinib (ST1571) in metastatic gastrointestinal stromal tumours: a phase Ⅰ study. Lancet, 2001, 358(9291):1421- 1423. 被引量:1
  • 8Demetri GD, van Mehren M, Blanke CD, et al. Efficacy and safety of imatinib mesylate in advanced gastrointestinal stromal tumors. N Engl J Med, 2002, 347(7) :472-480. 被引量:1
  • 9Heinrich MC, Corless CL, Blanke CD, et al. Molecular correlates of imatinib resistance in gastrointestinal stromal tumors. J Clin Oncol, 2006, 24(29):4764-4774. 被引量:1
  • 10Antonescu CR, Besmer P, Guo T, et al. Acquired resistance to imatinib in gastrointestinal stromal tumor occurs through secondary gene mutation. Clin Cancer Res, 2005, 11 (11) :4182-4190. 被引量:1

共引文献4

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部